Incilia Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 21.24%
- Ebitda 23.89%
- Net Worth -28.68%
- Total Assets -52.36%
About Incilia Therapeutics
Incilia Therapeutics Private Limited (ITPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 February 2017 (Eight years and two months 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Varma S and Joguparthi Vijay serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304TG2017PTC115390
- Company No.
115390
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Chemicals and Materials
Incilia Therapeutics Private Limited
Explore comprehensive data for Incilia Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Incilia Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varma S  | Director | 21-Feb-2017 | Current |
Joguparthi Vijay  | Director | 21-Feb-2017 | Current |
Financial Performance of Incilia Therapeutics.
Incilia Therapeutics Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 21.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Incilia Therapeutics?
In 2021, Incilia Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aizen Algo Private LimitedVarma S is a mutual person
Aizant Pharmaceuticals Private LimitedVarma S is a mutual person
- Aizant Drug Research Solutions Private Limited
Varma S is a mutual person
- Aizen Sim6 Private Limited
Varma S is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Incilia Therapeutics?
Unlock and access historical data on people associated with Incilia Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Incilia Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incilia Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Incilia Therapeutics
Recent activity within the organization
- Annual General Meeting
Incilia Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Incilia Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Varma Rudraraju S was appointed as a Director was appointed as a Director on 21 Feb 2017 & has been associated with this company since 8 years 2 months .
- Director Appointment
Joguparthi Vijay was appointed as a Director was appointed as a Director on 21 Feb 2017 & has been associated with this company since 8 years 2 months .
- Company Incorporation
Incilia Therapeutics Private Limited was registered on 21 Feb 2017 with Roc Hyderabad & aged 8 years 2 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Incilia Therapeutics Private Limited?
Incilia Therapeutics Private Limited was incorporated on 21 Feb 2017.
What is authorized share capital and paid-up capital of Incilia Therapeutics Private Limited?
The authorized share capital of Incilia Therapeutics Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Incilia Therapeutics Private Limited?
Currently 2 directors are associated with Incilia Therapeutics Private Limited.
- Varma Rudraraju S
- Joguparthi Vijay
What is the registered address of Incilia Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Incilia Therapeutics Private Limited is Flat No. 403 404 Sri Vensai Towers 4Th Floor Near Cine Planet, Kompally Vi Llage India, Quthbhullapur Mandal, Telangana, 500100.
What is the corporate identification number (CIN) and company number of Incilia Therapeutics Private Limited?
The corporate identification number (CIN) of Incilia Therapeutics Private Limited is U24304TG2017PTC115390 and the company number is 115390 as per Ministry of Corporate Affairs (MCA).
What is the official website of Incilia Therapeutics Private Limited?
The Official website of Incilia Therapeutics Private Limited is https://www.incilia.com
What change has been observed in the net worth of Incilia Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2021 indicates that The net worth of Incilia Therapeutics Private Limited has experienced an downturn of -28.68%.
When was the last Balance Sheet of Incilia Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Incilia Therapeutics Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records